A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Clinical trial NCT00853099 · COMPLETED

Trial details

NCT number: NCT00853099
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2009-02-01
Primary completion: 2011-05-01
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.